PRELUDE THERAPEUTICS INC
PRLD · NASDAQ
Updated at 2026-10-14 09:03:13
- Today's High
- $3.89
- Today’s Low
- $3.43
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $3.91
- Previous Close
- $3.74
- Volume
- 196.54K
- Market Cap
- $298.46M
- P/E Ratio
- --
- EPS
- $-0.73
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 175 INNOVATION BOULEVARD, WILMINGTON, DE, UNITED STATES, 19805
- Country
- US
- Listing Date
- 2020-09-25
- Fiscal Year End
- December
- Shares Outstanding
- 79.65M
- CIK
- 0001678660
- Website
- preludetx.com
Prelude Therapeutics Incorporated, a precision clinical-stage oncology company, focuses on the discovery and development of small molecule therapies optimized to target key drivers in cancers. The company is headquartered in Wilmington, Delaware.
Financial Metrics
Revenue
2026-06-30
$5.7M
2026-03-31
$4.58M
2025-12-31
$5.64M
2025-09-30
$6.5M
Operating Expenses
2026-06-30
$21.15M
2026-03-31
$18.36M
2025-12-31
$22.98M
2025-09-30
$26.91M
Net Income
2026-06-30
-$13.92M
2026-03-31
-$10.38M
2025-12-31
-$16.45M
2025-09-30
-$19.72M
Net Profit Margin
2026-06-30
-244.05%
2026-03-31
-226.74%
2025-12-31
-291.79%
2025-09-30
-303.46%
Earnings Per Share
2026-06-30
$-0.14
2026-03-31
$-0.13
2025-12-31
$-0.20
2025-09-30
$-0.26
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$13.56M
2026-03-31
-$9.99M
2025-12-31
-$16.03M
2025-09-30
-$19.3M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $5.7M | $4.58M | $5.64M | $6.5M |
| Operating Expenses | $21.15M | $18.36M | $22.98M | $26.91M |
| Net Income | -$13.92M | -$10.38M | -$16.45M | -$19.72M |
| Net Profit Margin | -244.05% | -226.74% | -291.79% | -303.46% |
| Earnings Per Share | $-0.14 | $-0.13 | $-0.20 | $-0.26 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$13.56M | -$9.99M | -$16.03M | -$19.3M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.